CPHI vs CRON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

CPHI

49.3
AI Score
VS
CRON Wins

CRON

60.3
AI Score

Investment Advisor Scores

CPHI

49score
Recommendation
HOLD

CRON

60score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CPHI CRON Winner
Revenue 983,536 45.21M CRON
Net Income -1.14M 13.75M CRON
Gross Margin 29.0% 42.4% CRON
Net Margin -116.2% 30.4% CRON
Operating Income -1.12M -1.83M CPHI
ROE -3.1% 1.3% CRON
ROA -2.5% 1.2% CRON
Total Assets 45.14M 1.17B CRON
Cash 168,474 821.86M CRON
Current Ratio 0.28 21.87 CRON

Relative Price Performance (Last 90 Days)

CPHI 1M: +64.8% · 3M: +118.4% CRON 1M: +1.4% · 3M: +5.7%

Current Technical Phase

CPHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.8 · Price: $1.13

CRON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.0% over 20 days), RSI 51

RSI (14): 50.6 · Price: $2.80

Fundamentals Snapshot

Metric CPHI CRON
Market Cap
Forward P/E 1.6 19.6
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth -0.1% 0.4%
Gross Margin 0.1% 0.4%
Operating Margin -1.1% 0.0%
EPS -0.54 0.00
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CRON is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.